`
`Serial No.: 15/187,721
`Attorney Docket No.: 44854-701305
`Page 1 /2
`
`In re the Application of:
`
`Group Art Unit:
`
`1798
`
`Inventors: William Banyai el al.
`
`Confirmation No.:
`
`6943
`
`Serial No:
`
`15/187,721
`
`Customer No:
`
`021971
`
`ELECTRONICALLY FILED: FEBRUARY 15: 2017
`
`Filing Date:
`
`June 20, 2016
`
`Patent No. US 9,555,388
`
`Title: DE NOVO SYNTHESIZED GENE
`
`Date of Patent: January 31, 2017
`
`LIBRARIES
`
`
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313-1450
`
`RES QUEST FOR CERTIFICATE OF CORRECTION OF THE ISSUED PATENT FOR
`OFFICE MISTAKE 137 C.F.R. § 1.322!
`
`Dear Commissioner:
`
`It is noted that an error appears in the above identified patent due to a mistake on the part
`
`of the Office, as more fully described below. The Patentee believes that correction thereof does
`
`not involve such changes in the patent as would constitute new matter or would require re-
`
`examination of the patent. A certificate of correction is therefore requested.
`
`Attached hereto is Form PTO/SB/44 which is suitable for printing.
`
`Patentee respectfully requests the Letters Patent be corrected as shown below:
`
`Column 237, line 47, Claim 1, the portion “distinct region comprising molecules
`capable of binding to a nucleoside phosphoramidite, and wherein each cluster is
`vertically aligned to a single well of the one or more wells.”
`should read -- distinct region comprising (i) a microwell comprising a single
`fiuidic opening, or (ii) a microchannel comprising two fluidic openings and
`extending through the second plate, and wherein each cluster is vertically aligned
`to a respective well. --
`
`Support for the correction to claim 1 can be found in the Amendment to Claim 1 posted
`
`by the Examiner in the Image File Wrapper on December 7, 2016, and referenced as entered by
`
`the Office on page 2 of the Notice of Allowability mailed December 7, 2016. Correction to
`
`
`
`Serial No.: 15/187,721
`Attorney Docket No.: 44854-701305
`Page 2 / 2
`
`claim 1 is to correct claim to be consistent with Claim 1 as amended in the December 7, 2016
`
`posting.
`
`There is no fee for the submission of this letter. However, the Commissioner is
`
`authorized to charge any fees which may be required or credit any overpayment to Deposit
`
`Account No. 23-2415 (Docket No. 44854-701305).
`
`Respectfully submitted,
`
`WILSON SONSINI GOODRICH & ROSATI
`
`Date: February 15, 2017
`
`By:
`
`/David S. Harburger/
`
`David S. Harburger
`
`Reg. No. 65,159
`
`650 Page Mill Road
`Palo Alto, CA 94304
`Phone: (858) 350-2322 (Direct)
`Fax: (650) 493-6811
`Customer No. 021971
`
`
`
`PTO/SB/44 (09-07)
`Approved for use through 08/31/2010. OMB 0651-0033
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`Also Form PTO-1050
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`CERTIFICATE OF CORRECTION
`
`PATENT NO.
`
`APPLICATION NO.
`
`ISSUE DATE
`
`|NVENTOR(S)
`
`:
`
`:
`
`:
`
`:
`
`9,555,388
`
`15/187,721
`
`January 31, 2017
`
`Page 1 of]
`
`Vlfilliam Banyai; Bill James Peck; Andres Fernandez; Siyuan Chen; Pierre Indermuhle
`
`aligned to a respective well. --
`
`It is certified that an error appears or errors appear in the above-identified patent and that said Letters Patent
`is hereby corrected as shown below.
`
`Column 237, line 47, Claim 1, the portion “distinct region comprising molecules capable of binding to a
`nucleoside phosphoramidite, and wherein each cluster is vertically aligned to a single well ofthe one or more
`wells.”
`
`should read -- distinct region comprising (i) a microwell comprising a single fluidic opening, or (ii) a microchannel
`comprising two fluidic openings and extending through the second plate, and wherein each cluster is vertically
`
`MAILING ADDRESS OF SENDER: (Please do not use customer number below)
`Wilson Sonsini Goodrich & Rosati
`
`650 Page Mill Road
`Palo Alto, California 94304
`This collection of information is required by 37 CFR 1.322, 1.323, and 1.324. The information is required to obtain or retain a benefit by the public which is to file
`(and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1.0 hour to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any
`comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
`U.S. Patent and Trademark Office, U.S. Department of Commerce, PO. 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS
`TO THIS ADDRESS. SEND TO: Attention Certificate of Corrections Branch, Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`
`If you need assistance in completing the form, caII 1-800-PTO-9199 and select option 2.
`
`8964113
`
`